NR3C1 and sarcoma: GCR cases missing hormone receptor status were also more likely to be diagnosed with duct and lobular type, mammary Paget disease, sarcomas, and “other” histologies, although as sarcomas are not amenable to hormonal treatment, it makes sense cases with these cancers may not necessarily be tested for hormone receptors.